Page last updated: 2024-08-25

bexarotene and Lymphoma, B-Cell, Marginal Zone

bexarotene has been researched along with Lymphoma, B-Cell, Marginal Zone in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, PL; Malachowski, SJ; Seminario-Vidal, L; Sun, J	1
Chu, J; Marmon, S; Meehan, S; Patel, R; Pomeranz, MK	1

Reviews

2 review(s) available for bexarotene and Lymphoma, B-Cell, Marginal Zone

Article	Year
Diagnosis and Management of Cutaneous B-Cell Lymphomas. Dermatologic clinics, 2019, Volume: 37, Issue:4 Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Anti-Bacterial Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Borrelia burgdorferi; Cyclophosphamide; Cytoreduction Surgical Procedures; Dermatologic Surgical Procedures; Disease Management; Doxorubicin; Humans; Injections, Intralesional; Lyme Disease; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Mechlorethamine; Polyethylene Glycols; Prednisone; Rituximab; Skin Neoplasms; Vincristine	2019
Recurrent localized primary cutaneous marginal-zone B cell lymphoma. Dermatology online journal, 2011, Oct-15, Volume: 17, Issue:10 Topics: Adult; Antigens, CD20; Arm; Bexarotene; Biomarkers, Tumor; Biopsy; Combined Modality Therapy; Humans; Ki-67 Antigen; Lymphoma, B-Cell, Marginal Zone; Male; Neoplasm Recurrence, Local; Proto-Oncogene Proteins c-bcl-2; Skin Neoplasms; Tetrahydronaphthalenes	2011

Article

Year

Diagnosis and Management of Cutaneous B-Cell Lymphomas.

Dermatologic clinics, 2019, Volume: 37, Issue:4

Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Anti-Bacterial Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Borrelia burgdorferi; Cyclophosphamide; Cytoreduction Surgical Procedures; Dermatologic Surgical Procedures; Disease Management; Doxorubicin; Humans; Injections, Intralesional; Lyme Disease; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Mechlorethamine; Polyethylene Glycols; Prednisone; Rituximab; Skin Neoplasms; Vincristine

2019

Recurrent localized primary cutaneous marginal-zone B cell lymphoma.

Dermatology online journal, 2011, Oct-15, Volume: 17, Issue:10

Topics: Adult; Antigens, CD20; Arm; Bexarotene; Biomarkers, Tumor; Biopsy; Combined Modality Therapy; Humans; Ki-67 Antigen; Lymphoma, B-Cell, Marginal Zone; Male; Neoplasm Recurrence, Local; Proto-Oncogene Proteins c-bcl-2; Skin Neoplasms; Tetrahydronaphthalenes

2011